This post first appeared on Micro Cap Daily

Vystar Corp. (OTC: VYST) has made a spectacular move up over the past few months from a start point of $0.0005 to recent highs well over a dime.

VYST has transformed since last December into a volume leader and is currently among the top most traded stocks on the bb’s. The stock has quickly attracted a fast growing shareholder base that continues to bid this one higher.

Based in Worcester, Mass., Vystar® Corporation (OTC Pink:VYST) is the exclusive creator of Vytex Natural Rubber Latex (NRL), a multi-patented, all-natural, raw material that contains significantly reduced levels of the proteins found in natural rubber latex and can be used in over 40,000 products. Vytex NRL is a 100% renewable resource, environmentally safe, “green” and fully biodegradable. Vystar is working with manufacturers across a broad range of consumer and medical products bringing Vytex NRL to market in adhesives, gloves, balloons, condoms, other medical devices and natural rubber latex foam mattresses, toppers, and pillows.

Vytex Natural Rubber Latex (NRL), a multi-patented, all-natural, raw material that contains significantly reduced levels of the proteins found in natural rubber latex and can be used in over 40,000 products. Vytex NRL is a 100% renewable resource, environmentally safe, “green” and fully biodegradable.

In December 2017 VYST announced the appointment of Steven Rotman as its Chief Executive Officer and member of the Board of Directors, appointment of three new members to its Board of Directors and relocation of its headquarters to Worcester, Massachusetts, effective immediately.  Mr. Rotman brings extensive management experience to Vystar.  He has been President and CEO of Rotmans, one of the oldest and largest furniture and carpet retailers in New England, for more than 40 years.  In addition he is the founder and managing partner of NHS Holdings, a company that in 2015 became the exclusive distributor of Vytex™ natural rubber latex foam in the U.S. and laid the groundwork for Vytex’s entrance to the home furnishings industry.

To Find out the inside Scoop on VYST Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

VYST has been making some big moves; in January VYST announced  the New England soft launch of Vytex(R) Cloud Bed-in-a-Box Collection of 100% all natural latex mattresses in three levels of support. The Bed-in-a-Box concept is a hit with consumers – transforming the $30 billion dollar a year mattress industry. Industry Bed-in-a-Box sales grew by 60% in 2017. In a society that is now comfortable with online sales and enjoys the convenience of to your door delivery, Bed-in-a-Box sales now account for nearly 30% of all mattress sales.

“Having spent 50 years in the furniture and bedding retail industry, it is rare to see a product category explode almost overnight like Bed-in-a-Box has,” stated Steve Rotman, CEO of Vystar and of Rotmans Furniture and Carpet. “We applied our expertise gained from decades of direct interactions with hundreds of thousands of New England consumers at Rotmans Furniture to help develop the high quality Vytex(R) Cloud Bed-in-a-Box with the convenience of online ordering and fast delivery right to your door. We’re proud to have Rotmans be the first retailer to offer the Vytex Cloud Bed-in-a-Box, manufactured by Symbol, at both our brick and mortar and online stores. Vystar will soon be rolling it out to other major online retailers.

On February 7, VYST announced it is resuming production of the Rx3000(TM), a hybrid air purifier designed by biomedical engineers specifically for hospitals. The Rx3000 combines powerful germicidal ultraviolet (UV) light with a patented 5-stage HEPA filtration proven in independent EPA- and FDA-certified laboratory testing to destroy on first pass over 99.97% of airborne viruses, bacteria and other contaminants. Vystar acquired the assets and patented intellectual property related to the Rx3000, RxAir(TM), custom filtration and other UV light air purification technologies from UV Flu Technologies in 2018 after production had stopped. Rx3000 is used in over 400 hospitals and is FDA-cleared as a Class II Medical Device. Priced at less than $5,000 per unit to service a 1,500 – 3,000 sq. ft. area, Rx3000 is very cost effective. Vystar also acquired all of the equipment necessary to make the custom filters used in the Rx3000. These large multi-stage filters retail for approximately $800 and last up to 1 year, depending on use. Vystar expects the first new Rx3000 units will be available to hospitals in the second quarter of 2019 via Vystar’s medical distribution network partners.

We have a Monster Pick Coming. Subscribe Right Now!

Currently trading at a $15.5 million market valuation VYST has $191k in the treasury, manageable debt and fast growing sales reporting $187,543 for the 3 months ended September 30, 2018 up from a few k for the same period last year. VYST is an exciting story developing in small caps; the Company ) is the exclusive creator of Vytex Natural Rubber Latex (NRL), a multi-patented, all-natural, raw material that contains significantly reduced levels of the proteins found in natural rubber latex and can be used in over 40,000 products. VYST is currently making a number of big moves including the soft launch of Vytex(R) Cloud Bed-in-a-Box Collection of 100% all natural latex mattresses and the production of the Rx3000(TM), a hybrid air purifier designed by biomedical engineers specifically for hospitals. We will be updating on VYST when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with VYST.

Sign Up now for our 100% FREE Penny Stock Newsletter

Disclosure: we hold no position in VYST either long or short and we have not been compensated for this article.

--
Copyright in text and images in this article belong to the original source.

This post first appeared on Micro Cap Daily

Tagged on: